| Member Request | | |
| 106#1h | Increase Funding for Commonwealth Research Commercialization Fund | $1,000,000 | $1,000,000 |
| 106#2h | Additional Funding for the Motion Picture Opportunity Fund | $4,500,000 | $4,500,000 |
| 106#3h | Continue Funding for National Security Agency Research | $350,000 | $350,000 |
| 106#4h | Eliminate New Funding for Biotechnology Spinoffs | -$30,000,000 | -$30,000,000 |
| 106#5h | Eliminate New Funding for Trade Missions | -$1,000,000 | -$1,000,000 |
| Committee Approved | | |
| 106#1h | Reduce New Funding for Trade Missions | -$500,000 | -$500,000 |
| 106#2h | Eliminate New Funding for Biotechnology Spinoffs | -$30,000,000 | -$30,000,000 |
| 106#3h | Additional Funding for the Motion Picture Opportunity Fund | $4,500,000 | $0 |
| 106#4h | Level Fund VBHRC | -$5,000,000 | -$7,500,000 |
| Floor Approved | | |
| 106#1h | Reduce New Funding for Trade Missions | -$500,000 | -$500,000 |
| 106#2h | Eliminate New Funding for Biotechnology Spinoffs | -$30,000,000 | -$30,000,000 |
| 106#3h | Additional Funding for the Motion Picture Opportunity Fund | $4,500,000 | $0 |
| 106#4h | Level Fund VBHRC | -$5,000,000 | -$7,500,000 |
| Conference Report | | |
| 106#1c | Eliminate New Funding for Biotechnology Spinoffs | -$30,000,000 | -$30,000,000 |
| 106#2c | Additional Funding for the Motion Picture Opportunity Fund | $3,000,000 | $0 |
| 106#3c | Transfer CRCF to CIT | -$2,800,000 | -$2,800,000 |
| 106#4c | Virginia Biosciences Health Research Corporation | -$5,000,000 | -$5,000,000 |
| 106#5c | Reduce Additional Funding for VEDP Trade Missions | -$500,000 | -$500,000 |